Clinical Trial: A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With Type 2 Diabetes Mellitus

U.S., Feb. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07433062) titled 'A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With Type 2 Diabetes Mellitus' on Dec. 23, 2025.

Brief Summary: The purpose of this study is to examine the effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants with Type 2 Diabetes Mellitus.

Study Start Date: Jan. 14

Study Type: INTERVENTIONAL

Condition: Type 2 Diabetes Mellitus

Intervention: DRUG: AZD6793

Participants will receive oral doses of metformin with an interval of 12 hours between doses. The morning doses of metformin will be administered together with AZD6793 (...